While they’ll have to pump the brakes for a bit longer than expected, as the race has been bumped a year to 2022, the Rice-based team is pushing forward with new designs introduced in the American Chemical Society’s Journal of Organic Chemistry.
The work led by chemists James Tour of Rice and Anton Dubrovskiy of the University of Houston-Clear Lake upgrades the cars with wheels of tert-butyl that should help them navigate the course laid out on a surface of gold, with pylons consisting of a few well-placed atoms.
Like their winning entry in 2017’s first international Nanocar Race, these nanocars have permanent dipole moments to increase their speed and drivability on the surface.
“The permanent dipoles make the cars more susceptible to being influenced by electric field gradients, which are used to propel and maneuver them,” Tour said. “It is a feature we introduced for the first competition, and I’m sure many of the entries will now have this advanced design element built into their nanocars.”
Rice University will roll up for the second international Nanocar Race with a new vehicle. The one-molecule car has a permanent dipole that makes it easier to control.
This year’s models are also lighter, a little more than the minimum 100 atoms required by new regulations. “The car we used in the first race had only 50 atoms,” Tour said. “So this is a substantial increase in the molecular weight, as required by the updated standards.
“It’s likely the race organizers wanted to slow us down since the last time, when we finished the 30-hour race in only 1.5 hours,” he said.
To bring the cars past 100 atoms while streamlining their syntheses, the researchers used a modular process to make five new cars with either all tert-butyl, all adamantyl wheels (as in previous nanocars) or combinations of the two.
At 90 atoms, cars with only butyl wheels, which minimize interactions with the track, and shorter chassis were too small. By using wheel combinations, the Rice lab made nanocars with 114 atoms. “This keeps the weight at a minimum while meeting the race requirements,” Tour said.
The nanocars will again be driven by a team from University of Graz in Austria led by Professor Leonhard Grill. The team brought the Rice vehicle across the finish line in 2017 and has enormous expertise in scanning tunneling microscope-directed manipulations, Tour said. The Grill and Tour groups will meet again in France for the race.
The overarching goal of the competition is to advance the development of nanomachines capable of real work, like carrying molecular-scale cargo and facilitating nano-fabrication.
“This race pushes the limits of molecular nanocar design and methods to control them,” Tour said. “So through this competitive process, worldwide expertise is elevated and the entire field of nanomanipulation is encouraged to progress all the faster.”
The race, originally scheduled for next summer, has been delayed by the pandemic. The racers will still need to gather in France to be overseen by the judges, but all of the teams will control their cars via the internet on tracks under scanning tunneling microscopes in their home labs.
“So the drivers will be together, and the cars and tracks will be dispersed around the world,” Tour said. “But the distance of each track will be identical, to within a few nanometers.”
The Rice-Graz entry won the 2017 race with an asterisk, as its car moved so quickly on the gold surface that it was impossible to capture images for judging. The team was then allowed to race on a silver surface that offered sufficient resistance and finished the 150-nanometer course in 90 minutes.
“The course was supposed to have been only 100 nanometers, but the team was penalized to add an extra 50 nanometers,” Tour said. “Eventually, it was no barrier anyway.” First prize on the gold track went to a Swiss team that finished a 100-nanometer course in six-and-a-half hours.
Tour’s lab built the world’s first single-molecule car in 2005 and it has gone through many iterations since, with the related development of molecular motors that drill through cells to deliver drugs.
Read the original article on Rice University.